Mirum Pharmaceuticals, Inc. MIRM Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s pre-tax income?
- Mirum Pharmaceuticals, Inc. (MIRM) reported pre-tax income of -$789.68M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s pre-tax income changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s pre-tax income decreased by 5686.0% year-over-year, from -$13.65M to -$789.68M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s pre-tax income?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s pre-tax income has grown at a -46.8% compound annual growth rate (CAGR), from -$142.07M to -$21.43M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.